Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours. [electronic resource]
Producer: 20130726Description: 1998-2004 p. digitalISSN:- 1532-1827
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Disease Progression
- Female
- Humans
- Male
- Melanoma -- drug therapy
- Middle Aged
- Neoplasms -- drug therapy
- Oligodeoxyribonucleotides -- administration & dosage
- Skin Neoplasms -- drug therapy
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.